Bristol-Myers Squibb Co (NYSE:BMY)
| 63.13 Delayed Data As of 4:35pm ET |  +1.31 / +2.12%Today’s Change | 45.32 Today|||52-Week Range 68.34 | -1.65% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 61.82 |
| Today’s open | 62.99 |
| Day’s range | 62.70 - 64.24 |
| Volume | 20,735,377 |
| Average volume (3 months) | 14,418,681 |
| Market cap | $137.5B |
Data as of 4:35pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | -33.05% |
| Earnings growth (this year) | +33.41% |
| Earnings growth (next 5 years) | +10.78% |
| Revenue growth (last year) | +15.89% |
| P/E ratio | NM |
| Price/Sales | 4.20 |
| Price/Book | 2.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.09 | -0.16% |
| LLYEli Lilly and Co | -1.61 | -1.05% |
| SNYSanofi | -0.09 | -0.18% |
| ABBVAbbVie | +0.15 | +0.16% |
Data as of 4:57pm ET, 08/11/2020
Financials
| Next reporting date | October 22, 2020 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 13.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
